Have a BMI of 27 or Higher? Researchers are studying an investigational once-daily oral tablet for adults who are overweight and NOT diagnosed with Type 2 diabetes. 

Start date
Multiple start dates
Therapy area(s)
Diabetes & metabolic health
Location
10 clinics
Compensation
Up to $3326
Overweight or Obese
Cardiovascular disease
Dyslipidemia
High Blood Pressure
High BMI
Hypertension
Obesity
Obstructive sleep apnea syndrome
Overweight
Weight loss

Requirements

Participants must meet the following inclusion criteria to be eligible for this clinical trial:

  • Male and female adults ≥18 years affected by excess weight or obesity
  • BMI ≥30
  •              OR
  •  BMI ≥27 with ≥1 weight-related comorbidity such as:
    • Sleep apnea
    • Dyslipidemia
    • Sleep apnea
    • Cardiovascular disease
  • Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight Eligibility will be confirmed by the Study Team
  • Don’t meet one of the criteria above? You may qualify for another study – please explore the full list at here https://trialmed.com/find-a-study/
Age: 18+
Sex: F or M
BMI: 27+
Smoker or non-smoker

About study

Researchers are evaluating an investigational oral GLP-1 medication for adults living with obesity or adults living with overweight and at least one weight-related health condition. Unlike many GLP-1 medications that are given by injection, the study medication is taken by mouth once each day.

Participants will also receive guidance on healthy eating and physical activity throughout the study.

Researchers want to learn more about the medication’s safety and how well it works for long-term weight management when combined with healthy lifestyle changes. Participation lasts about 72 weeks and includes study-related care at no cost. Qualified participants may also receive compensation for time and travel. 

Participation is voluntary, and you may leave the study at any time. 

Locations

Location Start date Status
Tucson Flexible start date
Register interest now
Austin Flexible start date
Enrolling now
Birmingham Flexible start date
Enrolling now
Evansville Flexible start date
Enrolling now
Huntsville Flexible start date
Enrolling now
Las Vegas Flexible start date
Enrolling now
Melbourne Flexible start date
Enrolling now
Phoenix Flexible start date
Enrolling now
San Antonio Flexible start date
Enrolling now
The Villages Flexible start date
Enrolling now

What’s the commitment?

Flexible

Once enrolled, the study may require multiple follow up visits. A study team member will share more details about the outpatient visit structure as part of your screening process.

How do I participate?

Register your interest

Let us know if you’re interested in a clinical trial!

Pre-qualification

We’ll review your medical history and match you with the study that makes sense for you.

Screening

Get all the details about the study, ask any questions you might have, and go through the health screening process (i.e. Labs, Physical Exam)

Enrollment

If you qualify, you’ll be invited to join the study. Once enrolled, you’re officially part of the research!

Want to find out more?

What are the benefits?

Advance potential treatment options

Every clinical research trial is aimed at getting new therapies to those in need. Some may have immediate results for participants while other are helping shape the future landscape of medicine.

No-cost Healthcare

Clinical trials offer a baseline of health assessments at no-cost to study participants. Many studies offer additional assessments and data that are above the standard of care that you would typically receive from your doctor.

Compensation for participation

Many clinical trials offer financial compensation for participation to help cover the cost of associated time, travel and inconvenience.

Improving the lives of yourself and others

Lack of participation in the research phase is a leading cause in delay of effective treatments to the public. No matter the benefit to you, your participation in a clinical trial is key to getting new therapies to the world.